Secobarbital

tripsit

secobarbital

Verificar en tripsit

psychonaut

Secobarbital

Verificar en psychonaut

isomerdesign

Secobarbital

Verificar en isomerdesign

pubchem

Secobarbital

Verificar en pubchem

druglab

Secobarbital

Verificar en druglab

drugmap

Secobarbital

Verificar en drugmap

wiki

Secobarbital

Verificar en wiki

SMILES:C=CCC1(C(C)CCC)C(O)=NC(=O)N=C1O

InChI:InChI=1S/C12H18N2O3/c1-4-6-8(3)12(7-5-2)9(15)13-11(17)14-10(12)16/h5,8H,2,4,6-7H2,1,3H3,(H2,13,14,15,16,17)

InChI key:KQPKPCNLIDLUMF-UHFFFAOYSA-N

Sinónimos: Secobarbital 1.0 mg/ml in Methanol, Evronal,5-(1-Methylbutyl)-5-(2-propen-1-yl)-2,4,6(1H,3H,5H)-pyrimidinetrione,(+-)-5-Allyl-5-(1-methylbutyl)-barbituric acid,Secobarbital suppository dosage form [DEA No. 2316],SECOBARBITAL [MART.],5-Allyl-5-(1-methylbutyl)malonylurea,Hypotrol,DEA No. 2315,BARBITURIC ACID, 5-ALLYL-5-(1-METHYLBUTYL)-, (+-)-,2,4,6(1H,3H,5H)-Pyrimidinitrione, 5-(1-methylbutyl)-5-(2-propenyl)-,5-pentan-2-yl-5-prop-2-enyl-1,3-diazinane-2,4,6-trione, Quinalbarbitone, 5-pentan-2-yl-5-prop-2-enyl-1,3-diazinane-2,4,6-trione,2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-(1-methylbutyl)-5-(2-propenyl)-, (+-)-,76-73-3, Pramil,5-(pentan-2-yl)-5-(prop-2-en-1-yl)-pyrimidine-2,4,6(1H,3H,5H)-trione,Secobarbital [USP:INN],SECOBARBITAL [INN],Secobarbital,(+-)-Secobarbital,Meballymal,Sodium quinalbarbitone,Secobarbital solution, 1.0 mg/mL in methanol, analytical standard, for drug analysis,CHEBI:9073,Secobarbital suppository dosage form,Imesonal (Salt/Mix),SECOBARBITAL [USP-RS], Seconal (TN),Secobarbitalum,5-24-09-00235 (Beilstein Handbook Reference), Meballymal, (+-)-Secobarbital, Secobarbital [USAN:INN], Hyptran,Quinalbarbital,SECOBARBITAL [VANDF],Secobarbitalum [INN-Latin],Secobarbitale [DCIT],Immenox,Q414788,SECOBARBITAL SODIUM FREE ACID [MI],5-Pentan-2-yl-5-prop-2-enyl-1,3-diazinane-2,4,6-trione, (+-)-5-Allyl-5-(1-methylbutyl)-barbituric acid, Secobarbital solution,Secobarbital solution, 1 mg/mL in methanol, ampule of 1 mL, certified reference material,5-(pentan-2-yl)-5-(prop-2-en-1-yl)-1,3-diazinane-2,4,6-trione,(RS)-Secobarbital,Secobarbitale,(+/-)-Secobarbital,Secobarbital, United States Pharmacopeia (USP) Reference Standard, Somosal,5-allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione, 5-(1-methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione,CHEMBL447,Somatarax,(+/-)-Quinalbarbitone, 5-Allyl-5-(1-methylbutyl)barbiturate,Meballymalum, 5-Allyl-5-(1-methylbutyl)malonylurea, Quinalbarbital,SCHEMBL11110602, 5-(pentan-2-yl)-5-(prop-2-en-1-yl)-pyrimidine-2,4,6(1H,3H,5H)-trione,5-(1-methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione, 5-ALLYL-5-(1-METHYLBUTYL)BARBITURIC ACID, Secobarbital suppository dosage form,2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-(1-methylbutyl)-5-(2-propenyl)-, (+-)- (9CI),Secobarbital (USP/INN),2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-(1-methylbutyl)-5-(2-propenyl)-, Seconal, Secobarbitone,Quinalbarbitone, 5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione,Somosal,SCHEMBL80734,Hyptran (Salt/Mix),Secobarbital sodium free acid,SECOBARBITAL [HSDB],(.+/-.))-Secobarbital,BRN 0225330, Secobarbitalum,Trisomnin (Salt/Mix),2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-(1-methylbutyl)-5-(2-propen-1-yl)-,HSDB 3182, Secobarbitale, Seotal,EINECS 200-982-2, Secobarbitale [DCIT],DTXSID6044145,Seconal (TN),Seconal,SECOBARBITAL [USP IMPURITY], Secobarbitalum [INN-Latin], 2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-(1-methylbutyl)-5-(2-propenyl)-, (+-)-(9CI),29071-21-4,seconal,GTPL7615,Immenoctal (Salt/Mix),NCGC00247712-01,5-allyl-5-(1-methylbutyl)-barbituric acid,Secobarbital cii, 5-allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione,secobarbital,Secobarbital 0.1 mg/ml in Methanol,Sodium secobarbital,DB00418,Barbosec,UNII-1P7H87IN75,S0223,5-Allyl-5-(1-methylbutyl)barbiturate,Evronal,5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione,Secobarbital, analytical standard,D00430, Hypotrol,Secobarbitone,5-ALLYL-5-(1-METHYLBUTYL)BARBITURIC ACID, Meballymalum,SECOBARBITAL [WHO-DD],1P7H87IN75,Hyptran,Barbituric acid, 5-allyl-5-(1-methylbutyl)-

Similitudes

Poder identificar moléculas similares a la que estudiamos puede permitir inferir algunas de sus propiedades. Hay varias formas de medir la similitud entre moléculas, por su estructura, efectos, interacciones farmacológicas, etc. A continuación, puedes encontrar moléculas similares según varios criterios y herramientas que desarrollamos. Para comprender las limitaciones de estas comparaciones, es crucial referirse siempre a la metodología utilizada para medir esas similitudes.Ten en cuenta: Esta información se proporciona únicamente con fines informativos y no debe interpretarse como asesoramiento médico.

Para medir la similitud estructural, utilizamos el método de Mol2vec Mol2Vec, que es una red neuronal que procesa moléculas y las transforma en puntos en el espacio, de modo que las moléculas con subestructuras químicamente relacionadas se transforman en puntos cercanos en el espacio.

Propiedades de la molécula

Utilizando el modelo de KGPT Aprendizaje Profundo, predecimos varias propiedades de la molécula. Las predicciones se agrupan según el conjunto de datos que se utilizó para obtener esas predicciones. Junto con cada predicción, proporcionamos un gráfico que muestra la distribución de los valores predichos en el conjunto de datos de entrenamiento/prueba/validación. Esto da una estimación de la confiabilidad del modelo.

Description: A dataset focused on predicting the inhibitory effects of molecules on the enzyme beta-secretase 1 (BACE1). BACE1 inhibition is a potential target for Alzheimer's disease treatment.
Class
TrainValTest
2.88-3.70-1.36
Description: A dataset providing insights on the ability of molecules to penetrate the blood-brain barrier. Crucial for understanding the potential of molecules as central nervous system drugs.
p_np
TrainValTest
-2.24-3.290.40
Description: This dataset deals with the FDA approval status and clinical trial toxicity of molecules. Important for understanding the safety and regulatory status of compounds.
CT_TOX
TrainValTest
-0.49-0.78-0.91
FDA_APPROVED
TrainValTest
0.53-1.27-0.50
Description: A dataset that predicts the solubility of molecules in water. Solubility is an essential property influencing bioavailability and the potential formulation of a drug.
logSolubilitylog(mol/L)
0.39
TrainValTest
Description: This dataset is centered on predicting the free energy when a molecule is dissolved in water. The energy changes can affect molecular interactions in biological systems.
freesolvkcal/mol
-2.00
TrainValTest
Description: A dataset predicting the lipophilicity of molecules. Lipophilicity is a crucial factor affecting the distribution, metabolism, and excretion of drugs in the body.
lipoAlogP
-0.89
TrainValTest
Description: This dataset gives insights into the metabolic stability of molecules. High metabolic stability often results in a longer half-life, influencing drug dosage and frequency.
low
TrainValTest
-0.17-3.50-2.88
high
TrainValTest
0.72-3.55-0.49
27 entries
12 entries
617 entries

Perspectivas avanzadas

En lo siguiente, proporcionamos un análisis más avanzado sobre las interacciones de una molécula con el metabolismo humano, sitios de acoplamiento, etc.

Interacción de esta molécula con el metabolismo

Utilizamos un modelo de Aprendizaje Profundo para predecir las interacciones de esta molécula con el metabolismo. Consulta la fuente para entender la metodología.

Reacciones que metabolizan esta molécula
Hydroxylation of antepenultimate aliphatic secondary carbon BTMR1072
Enzimas: CYP1A2 CYP2E1
Reagents

Metabolite: InChI=1S/C12H18...

Allylic hydroxylation BTMR1091
Reagents

Metabolite: InChI=1S/C12H18...

Hydroxylation of penultimate aliphatic secondary carbon BTMR1074
Reagents

Metabolite: InChI=1S/C12H18...

Epoxidation of alkene BTMR0109
Reagents

Metabolite: InChI=1S/C12H18...

Hydroxylation of terminal methyl BTMR1061
Reagents

Metabolite: InChI=1S/C12H18...

Hydroxylation of terminal methyl BTMR1061
Reagents

Metabolite: InChI=1S/C12H18...

Terminal desaturation BTMR1190
Reagents

Metabolite: InChI=1S/C12H16...

Terminal desaturation BTMR1190
Reagents

Metabolite: InChI=1S/C12H16...

Hydroxylation of penultimate aliphatic tertiary carbon BTMR1075
Reagents

Metabolite: InChI=1S/C12H18...